From Breakthroughs Blog: DoD

 
Flickr/55thstreet
Global health and medical research saved from the chopping block in 2018 spending bill

What global health R&D advocates need to know about the 2018 omnibus spending bill.

Read More
PATH/Aaron Joel Santos
Five issues to watch in US global health R&D policy in 2018

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

GHTC
Read More
Photo: White house/Shealah Craighead
Medical research, global health programs face steep cuts in Trump budget

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

GHTC
Read More
Architect of the Capitol
Global health and medical research saved from spending cuts in FY17 budget agreement

What global health R&D advocates need to know about the FY2017 budget agreement.

GHTC
GHTC
Read More
Office of Management and Budget
Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research

What global health advocates need to know about the President's "skinny" budget.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: A virus-killing mask, testing drugs on pregnant women, and DARPA’s global health portfolio

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Update on Zika R&D

In this regular feature on Breakthroughs, we highlight the most promising Zika virus vaccine, drug, and diagnostic candidates as well as vector control approaches. 

GHTC
Read More
US Navy
Senate votes to protect medical research at DoD

Today the US Senate voted to protect critical medical research programs at the Department of Defense (DoD).

GHTC
Read More
Research Roundup: Vaccines for Rift Valley Fever, MERS, and Zika

A vaccine candidate against Rift Valley Fever appears to be safe and effective for livestock and has the potential for use in humans.

GHTC
Read More
CDC/Dr. Scott Smith
Research Roundup: an HIV/AIDS vaccine candidate, inflatable incubator for premature babies, and US government R&D

Dr. Robert Gallo co-discovered the HIV virus and subsequently led the development of the first HIV/AIDS blood test.

GHTC
Read More
Research Roundup: Appropriations, Ebola, AIDS 2014, open working groups, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Senate shows strong support for global health R&D in defense appropriations bill and report

Earlier this month, we reported that both the House and Senate Appropriations Committees included language supporting global health research and development (R&D) in their reports concerning funding for the Department of State, foreign operations and related programs.

Read More
How R&D is saving #momandbaby and helping children reach their #5thbday

Tomorrow US policymakers and global health advocates will come together to talk progress made on preventing maternal and child deaths.

Read More
PATH/Will Boase
Congress acts on FY 2015 funding; shows lukewarm support for global health R&D

As the DC summer kicks into full swing, Congress has had a busy month moving forward fiscal year (FY) 2015 funding legislation for a variety of government programs including global health research and development (R&D).

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Ken Kistler
Congressional budget justifications shed light on FY 2015 global health R&D priorities

As more detailed information about the President’s fiscal year (FY) 2015 budget requests to Congress is released, the results continue to be a mixed bag for global health research and development (R&D).

GHTC
Read More
Obama Administration’s FY 2015 budget request sends mixed signals on global health R&D

Yesterday, the White House released President Obama’s much-anticipated budget request for fiscal year (FY) 2015.

GHTC
Read More
Ken Kistler
Congress passes FY 2014 Omnibus package: Mixed results for global health research

In an increasingly rare show of bipartisanship, Congress has moved forward an appropriations agreement that should finally settle the issue of fiscal year (FY) 2014 funding levels.

GHTC
Read More
Three key research developments you might have missed from the ASTMH Annual Meeting

In this guest post, Jaclyn Schiff—American Society of Tropical Medicine and Hygiene (ASTMH) Director of Communications—highlights news in global health research presented during the recent ASTMH Annual Meeting.

Read More
Impacts of federal budget compromise emerging

After two-and-a-half weeks in limbo, government employees were able to return to work on October 17th—when Congress finally reached a temporary agreement to re-open the government.

GHTC
Read More
New fact sheet outlines the global health R&D pipeline and why US support is so important

In the past, the United States has contributed to important breakthroughs in global health—from the eradication of smallpox to a 74 percent drop in measles deaths worldwide.

GHTC
Read More
Architect of the Capitol
Federal budget update, Part 2: DoD, CDC, FDA, and NIH

As we discussed yesterday, lawmakers in the House and Senate have been busy with several pieces of legislation that would fund global health and research efforts across the federal government.

GHTC
Read More
US government collaborations protect and improve global health

In this guest post, Heather Ignatius, senior policy and advocacy officer at PATH, writes about the important role US agencies play in advancing global health technologies.

PATH
Read More